Global Iron Deficiency Anemia Market By Therapy Type (Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion), By Therapy Area (Obstetrics and Gynecology, Renal Diseases, Congestive Heart Failure (CHF), Oncology, Inflammatory Bowel Disease and Others), By Patient (Adults, Geriatric, Pediatric), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By End-User (Hospitals, Specialty Clinics, Home Care Setting and Others) Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025-2034
- Published date: March 2025
- Report ID: 141779
- Number of Pages: 373
- Format:
-
keyboard_arrow_up
-
-
- AbbVie Inc. Company Profile
- Akebia Therapeutics Inc.
- AMAG Pharmaceuticals Inc. (Covis Group S.à r.l.)
- Daiichi Sankyo Company
- Pharmacosmos A/S
- Sanofi S.A.
- Johnson & Johnson
- Fresenius SE & Co. KGaA
- CSL Vifor
- Rockwell Medical, Inc.
- Akorn Operating Company LLC
- Shield Therapeutics plc
- AdvaCare Pharma
- Otsuka Pharmaceutical Co., Ltd.
- Sun Pharmaceutical Industries Ltd.
- Other key players
- settingsSettings
Our Clients
- 141779
- March 2025
Trusted by more than 17382 organizations globally
✖
Request a Sample Report
We'll get back to you as quickly as possible
|
Single User
$6,000
$3,999
USD / per unit
save 24%
|
Multi User
$8,000
$5,999
USD / per unit
save 28%
|
Corporate User
$10,000
$6,999
USD / per unit
save 32%
|
|
|---|---|---|---|
| e-Access | |||
| Report Library Access | |||
| Data Set (Excel) | |||
| Company Profile Library Access | |||
| Interactive Dashboard | |||
| Free Custumization | No | up to 10 hrs work | up to 30 hrs work |
| Accessibility | 1 User | 2-5 User | Unlimited |
| Analyst Support | up to 20 hrs | up to 40 hrs | up to 50 hrs |
| Benefit | Up to 20% off on next purchase | Up to 25% off on next purchase | Up to 30% off on next purchase |
| Buy Now ($ 3,999) | Buy Now ($ 5,999) | Buy Now ($ 6,999) |
